JAK2 c.455del ;(p.Y152Sfs*15)

Variant ID: 9-5044507-TA-T

NM_004972.3(JAK2):c.455del;(p.Y152Sfs*15)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma.

Haematologica
Bastidas Torres, Armando N AN; Cats, Davy D; Out-Luiting, Jacoba J JJ; Fanoni, Daniele D; Mei, Hailiang H; Venegoni, Luigia L; Willemze, Rein R; Vermeer, Maarten H MH; Berti, Emilio E; Tensen, Cornelis P CP
Publication Date: 2022-03-01

Variant appearance in text: JAK2: 455delA
PubMed Link: 33792220
Variant Present in the following documents:
  • 2020_274506_TORRES_SUPPL.pdf
View BVdb publication page